35
20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T28072L | MLN-3897 TFA | MLN-3897 TFA(1010731-97-1 Free base) | CCR |
MLN-3897 TFA is a potent CCR1 antagonist that inhibits the binding of 125I-MIP-1α to THP-1 cell membranes. | |||
T16116 | MLN-4760 | RAAS | |
MLN-4760 is an angiotensin-converting (ACE2) inhibitor(human ACE2;IC50=0.44 nM). It also has excellent selectivity (>5000-fold) versus related enzymes including human testicular ACE (IC50, >100 μM) and bovine carboxypept... | |||
T71380 | MLN-0415 | ||
MLN-0415 is an IKK2 inhibitor which decreases NF-κB activation and down-regulates the expression of a number of inflammatory proteins. | |||
T35187 | XR 5944 | XR-5944,MLN-944,MLN944,XR5944,MLN 944 | |
XR 5944 is an effective DNA binder that stabilizes topoisomerase-dependent cleavage and has shown superior efficacy in a variety of mouse and human tumor models. | |||
T77118 | Plozalizumab | MLN-1202 | CCR |
Plozalizumab (MLN-1202) is a humanized selective and potent anti-CCR2 antibody.Plozalizumab has antitumor activity.Plozalizumab is used in the study of malignant melanoma. | |||
T68427 | MLN-3897 citrate | ||
MLN-3897 citrate is a C-C Motif Chemokine Receptor 1 (CCR1) antagonist potentially for the treatment of multiple sclerosis and rheumatoid arthritis. | |||
T28072 | MLN-3897 | AVE9897,AVE 9897,CCR1 antagonist 10,AVE-9897 | CCR |
MLN-3897 (CCR1 antagonist 10) is an orally active antagonist of CCR1 with a Ki of 2.3 nM for 125I-MIP-1α binding to THP-1 cell membranes. MLN-3897 inhibits Akt signaling and MM cell survival and proliferation. | |||
T2241 | Alisertib | MLN 8237 | Apoptosis , Aurora Kinase , Autophagy |
Alisertib (MLN 8237) is a specific Aurora A inhibitor (IC50: 1.2 nM). The selectivity of Alisertib(MLN 8237) is >200-fold higher for Aurora A than Aurora B. | |||
T72913 | (R)-MLN-4760 | ||
(R)-MLN-4760, the R-enantiomer of MLN-4760, functions as an ACE2 inhibitor and exhibits a half maximal inhibitory concentration (IC50) of 8.4 μM, identifying it as the less active isomer. | |||
T6315 | MLN8054 | Casein Kinase , PKA , Src , Aurora Kinase | |
MLN8054 is a potent and selective Aurora A kinase inhibitor with an IC50 of 4 nM. | |||
T2016 | MLN9708 | Ixazomib Citrate | Proteasome |
MLN2238 suppresses the chymotrypsin-like proteolytic (β5) site of the 20S proteasome(Ki50=0.93 nM, IC50=3.4 nM/). The biologically active form of MLN9708 (Ixazomib Citrate) is MLN2238 in aqueous solutions or plasma. | |||
T2704 | MLN0905 | PLK1 Inhibitor | PLK |
MLN0905 (PLK1 Inhibitor) is an effective PLK1 inhibitor(IC50=2 nM). | |||
T6332 | Pevonedistat | MLN4924 | E1/E2/E3 Enzyme , NEDD8 |
Pevonedistat (MLN4924) is a potent and selective NEDD8 activating enzyme (NAE) inhibitor (IC50=4.7 nM). Pevonedistat can be used for the treatment of myelodysplastic syndromes (MDS) and also has antitumor activity. | |||
T2122 | Ixazomib | MLN2238 | Proteasome , Caspase , Autophagy |
Ixazomib (MLN2238) , a second generation, boron-containing peptide proteasome inhibitor (PI), inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome (IC50/Ki: 3.4/0.93 nM, in cell-free assays), also i... | |||
T8397 | Ixazomib citrate | MLN9708 | Proteasome , Autophagy |
Ixazomib citrate (MLN9708) is a prodrug of Ixazomib (MMLN-2238). MLN9708 is an orally bioavailable second generation proteasome inhibitor (IC50 of 3.4 nM ) with potential antineoplastic activity. | |||
T26339 | XR-11576 | MLN-576,MLN 576,MLN576,XR 11576 | |
XR-11576 is a DNA topoisomerase I and II inhibitor for the treatment of solid tumors. | |||
T80554 | Myoregulin | MLN peptide | Calcium Channel |
Myoregulin (MLN peptide), a regulin family member, modulates muscle performance through intracellular calcium handling. It directly interacts with the sarcoplasmic reticulum Ca^2+-ATPase (SERCA), impeding Ca^2+ uptake in... | |||
T80555 | Myoregulin TFA | MLN peptide TFA | Calcium Channel |
Myoregulin (MLN peptide) TFA, belonging to the regulin family, is a regulator of muscle performance through modulation of intracellular calcium dynamics. It specifically interacts with sarcoplasmic reticulum Ca2+-ATPase ... | |||
T38428 | Alisertib sodium | MLN 8237 sodium | |
Alisertib sodium (MLN 8237) is a potent and specific inhibitor (IC50 = 1.2 nM) of Aurora A kinase, an enzyme involved in cell division. By binding to Aurora A kinase, Alisertib sodium disrupts the formation of the mitoti... | |||
T6895 | TAK-580 | MLN2480,BIIB-024 | Raf |
TAK-580 (MLN2480) is an oral, selective pan-Raf kinase inhibitor in Clinicalal trials. | |||
T3153 | Serabelisib | TAK-117,INK1117,MLN1117 | PI3K , mTOR |
Serabelisib (INK1117) is a p110α/β/γ/δ inhibitor (IC50: 15/4.5/1.9/13.39 μM). | |||
T1838 | Sapanisertib | TAK-228,MLN0128,INK 128 | PI3K , mTOR , Autophagy |
Sapanisertib (INK 128) is an orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity. | |||
T16974 | TAK-243 | MLN7243 | Apoptosis , E1/E2/E3 Enzyme , NF-κB |
TAK-243 (MLN7243) is a selective inhibitor of the ubiquitin-activating enzyme UAE (IC50=1 nM). TAK-243 blocks ubiquitin binding and disrupts mono-ubiquitin signaling as well as overall protein ubiquitination. TAK-243 exh... | |||
TQ0306 | MLN120B | IκB/IKK | |
MLN120B is a selective and ATP competitive IKKβ inhibitor (IC50: 60 nM). | |||
T1667 | Tandutinib | MLN518,CT53518,NSC726292 | Apoptosis , FLT , CSF-1R , PDGFR , Src , c-Kit |
Tandutinib (CT53518) (MLN518, CT53518), an effective FLT3 antagonist (IC50: 0.22 μM), can also inhibit c-Kit and PDGFR, 15-20 fold higher potency for FLT3 versus CSF-1R and >100-fold selectivity for the same target versu... | |||
T68489 | MLN8054 sodium | ||
MLN8054 sodium is an Aurora A inhibitor. | |||
T69982 | VPC-16606 | ||
VPC-16606 is a potent and selective inhibitor of ERα-dependent cell growth and gene expression. VPC-16606 prevents the interaction between ERα-LBD and SRC-3 fusion proteins in a dose-dependent manner. | |||
T71378 | Exp9270 | ||
Exp9270 is an Angiotensin II receptor antagonist. | |||
T16117 | Pevonedistat hydrochloride | MLN4924 hydrochloride | Others |
Pevonedistat hydrochloride is an effective and selective inhibitor of NEDD8-activating enzyme (IC50: 4.7 nM). | |||
T69889 | JBP485 | ||
JBP485 is an inhibitor of renal transporters OAT1 and OAT3. JBP485 is an antihepatitis agent as a substrate for intestinal PEPT1. | |||
T23418 | Tandutinib (MLN518) HCl | Others | |
Tandutinib is an effective antagonist for FLT3, platelet-derived growth factor receptor (PDGFR), and c-Kit. Tandutinib potently inhibited the activity of FLT3, PDGFR, and c-Kit (IC50: ~200 nM). | |||
T39199 | ML 120B dihydrochloride | ML120B dihydrochloride | |
MLN120B dihydrochloride (ML120B dihydrochloride) is a highly potent, orally active inhibitor of IKKβ. It competitively binds to ATP and exhibits an impressive IC50 value of 60 nM. This compound effectively suppresses the... | |||
T80770 | Wt hMLN TFA | ||
WT hMLN (TFA) is a microprotein that functions as an inhibitor of the SR Ca2+ pump (SERCA), playing a crucial role in the regulation of calcium homeostasis in skeletal muscle [1]. | |||
T80556 | Wt hMLN | Calcium Channel | |
Wild-type human myoregulin (wt hMLN) is a microprotein that inhibits the sarcoplasmic reticulum Ca²⁺ pump (SERCA), playing a crucial role in the regulation of calcium homeostasis in skeletal muscle [1]. | |||
T62660 | MLN3126 | ||
MLN3126 is an orally active, potent CCR9 antagonist. MLN3126 inhibits CCL25-induced calcium mobilization and chemotaxis in mouse primary thymocytes with an IC50 value of 6.3 nM for calcium influx inhibition. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04207 | Motilin Protein, Human, Recombinant (His) | Human | HEK293 Cells |
MLN (Motilin) is a Protein Coding gene. 3 alternatively spliced human isoforms have been reported. This gene encodes a small peptide hormone that is secreted by cells of the small intestine to regulate gastrointestinal c... | |||
TMPY-04698 | HER2/ERBB2 Protein, Human, Recombinant (aa 489-630, His) | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (aa 489-630, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 17.1 kDa and the accession number is P04626-1. | |||
TMPY-05239 | HER2/ERBB2 Protein, Human, Recombinant , Biotinylated | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant , Biotinylated is expressed in HEK293 mammalian cells. The predicted molecular weight is 70 kDa and the accession number is P04626-1. | |||
TMPY-04684 | HER2/ERBB2 Protein, Human, Recombinant (aa 1-195, His) | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (aa 1-195, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 20.9 kDa and the accession number is P04626-1. | |||
TMPY-00167 | HER2/ERBB2 Protein, Human, Recombinant | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 70 kDa and the accession number is P04626-1. | |||
TMPY-01137 | HER2/ERBB2 Protein, Human, Recombinant (aa 1-652, His) | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (aa 1-652, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 71 kDa and the accession number is P04626-1. | |||
TMPK-00428 | HER2/ErbB2 Protein, Human, Recombinant (His & Avi) | Human | HEK293 Cells |
ErbB2, also called Neu and Her2 (human epidermal growth factor receptor 2), is a type I membrane glycoprotein that is a member of the ErbB family of tyrosine kinase receptors. ErbB family members serve as receptors for t... | |||
TMPK-00429 | HER2/ERBB2 Domain 4 Protein, Human, Recombinant (His & Avi) | Human | HEK293 Cells |
HER2/ERBB2 Domain 4 Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 18.5 kDa and the accession number is P04626-1. | |||
TMPK-00430 | HER2/ERBB2 Domain 4 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
HER2/ERBB2 Domain 4 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 18.5 kDa and the accession number is P04626-1. | |||
TMPJ-00778 | HER2/ERBB2 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 90-120 KDa and the accession number is P04626. | |||
TMPY-05754 | HER2/ERBB2 Protein, Human, Recombinant (aa 489-630, His), Amine-Labeled Biotinylated | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (aa 489-630, His), Amine-Labeled Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 17.1 kDa and the accession number is AAA75493.1. | |||
TMPY-05315 | HER2/ERBB2 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 72.6 kDa and the accession number is P04626-1. | |||
TMPY-06612 | HER2/ERBB2 Protein, Human, Recombinant (mFc) | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 95.75 kDa and the accession number is NP_004439.2. | |||
TMPY-00745 | HER2/ERBB2 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 96.1 kDa and the accession number is P04626-1. | |||
TMPY-04538 | HER2/ERBB2 Protein, Human, Recombinant (aa 676-1255, His & GST) | Human | Baculovirus Insect Cells |
HER2/ERBB2 Protein, Human, Recombinant (aa 676-1255, His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 92 kDa and the accession number is P04626-1. | |||
TMPY-05368 | HER2/ERBB2 Protein, Human, Recombinant (hFc), Biotinylated | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (hFc), Biotinylated is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 96.1 kDa and the accession number is P04626-1. | |||
TMPY-04955 | HER2/ERBB2 Protein, Human, Recombinant (His), Amine-Labeled Biotinylated | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (His), Amine-Labeled Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 71 kDa and the accession number is P04626-1. | |||
TMPY-01331 | S100A11 Protein, Human, Recombinant | Human | E. coli |
S100A11 Protein, Human, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 24 and 12 kDa and the accession number is P31949. | |||
TMPJ-00777 | HER2/ERBB2 Protein, Human, Recombinant (aa 23-652, hFc) | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (aa 23-652, hFc) is expressed in HEK293 mammalian cells with C-Fc tag. The predicted molecular weight is 120-145 KDa and the accession number is P04626. | |||
TMPJ-00776 | HER2/ERBB2 Protein, Human, Recombinant (hFc & Avi), Biotinylated | Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-Fc-Avi tag. The predicted molecular weight is 120-140 KDa and the accession number is P04626. |